Leuko

medical devices

About

Leuko is a medical technology company based in Kendall Square, Cambridge, Massachusetts, and is an MIT spinout focused on hematology innovation. The company is developing PointCheck™, the first non-invasive device for monitoring white blood cell levels. This technology aims to enhance the quality of life for immunosuppressed patients, particularly those undergoing chemotherapy, by allowing convenient at-home monitoring without the need for blood draws. PointCheck™ is a portable device that uses light to image blood cells in capillaries near the fingernail. AI algorithms analyze these images to determine white blood cell levels. The device is currently investigational and not yet available for sale. Leuko's mission includes reducing hospital admissions related to low white blood cell counts and addressing the healthcare costs associated with chemotherapy. The company is committed to fostering a collaborative environment and aims to expand its impact globally through strategic partnerships and clinical studies.

Technologies

Gmail Google Apps Cloudflare DNS Typekit Google Tag Manager Google Analytics Mobile Friendly IoT Remote

Keywords

medical devices diagnostics medical technology clinical imaging bioengineering medical equipment manufacturing optical imaging medical diagnostics immunosuppressed patient care neutropenia detection blood flow imaging regulatory compliance neutropenia screening machine learning in healthcare nailfold capillary imaging healthcare equipment & supplies ai biomedical imaging healthtech innovation medical equipment and supplies manufacturing reverse lens microscopy superficial capillary blood flow medical device innovation biomedical signal processing home diagnostics medical ai clinical validation medical device development ai-based blood analysis biotechnology portable medical device

Location

8 St Marys St, Boston, Massachusetts, United States, 02215

Related Companies

Companies in the same industry